Endogastric solutions initially became aware of a potential adverse event on 22 march 2022.After multiple documented attempts to obtain information, it was not until 18 may 2022 when this adverse event was confirmed by the physician.The physician is not alleging a product malfunction caused or contributed to the patient adverse event and the product was not returned to endogastric solutions (egs) for evaluation.The device was discarded at the medical facility by the hospital staff and is unavailable for return to egs.The physician is alleging the tif procedure may have caused/contributed to the reported esophageal leak as well as the reported uncontrollable retching and vomiting after the procedure.Based on the available information received by egs, the cause of the reported incident could not be conclusively determined.
|
Updating health effect clinical code (e) to only include: 2399, 1776, and 1858.Updating health effect impact code (f) to only include: 4614, 4621, 4641, and 4607.Updating type of investigation (b) to only include: 4112, 4109, 4110, 4115, and 4111.
|